Howe & Rusling’s Precision BioSciences DTIL Stock Holding History

Howe & Rusling’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5	Closed	–	–	1089
2022 Q2	$0	Buy	+5	New	+$294	﹤0.01%	1086

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Howe & Rusling's DTIL Position: Q3 2022 in Review

Howe & Rusling sold out of Precision BioSciences (DTIL) in Q3 2022, closing a stake of 5 shares.

Howe & Rusling first reported a position in DTIL in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 102 funds tracked by Wall St. Rank hold DTIL as of Q3 2022.

Howe & Rusling reported no remaining Precision BioSciences position as of Q3 2022 after selling out during the quarter.
Howe & Rusling sold 5 Precision BioSciences shares in Q3 2022.
Howe & Rusling first reported a position in Precision BioSciences in Q2 2022 and held it in 1 quarter.
Howe & Rusling's Precision BioSciences position peaked at $0 in Q2 2022.
102 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.